Fancl Corp
TSE:4921
Fancl Corp
Operating Income
Fancl Corp
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
F
|
Fancl Corp
TSE:4921
|
Operating Income
¥11.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
14%
|
Shiseido Co Ltd
TSE:4911
|
Operating Income
¥29B
|
CAGR 3-Years
25%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
-5%
|
|
Rohto Pharmaceutical Co Ltd
TSE:4527
|
Operating Income
¥40.6B
|
CAGR 3-Years
25%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
Pola Orbis Holdings Inc
TSE:4927
|
Operating Income
¥16.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
0%
|
|
Kao Corp
TSE:4452
|
Operating Income
¥60B
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-7%
|
|
Kobayashi Pharmaceutical Co Ltd
TSE:4967
|
Operating Income
¥25.8B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
4%
|
See Also
What is Fancl Corp's Operating Income?
Operating Income
11.5B
JPY
Based on the financial report for Dec 31, 2023, Fancl Corp's Operating Income amounts to 11.5B JPY.
What is Fancl Corp's Operating Income growth rate?
Operating Income CAGR 10Y
14%
Over the last year, the Operating Income growth was 47%. The average annual Operating Income growth rates for Fancl Corp have been 3% over the past three years , -1% over the past five years , and 14% over the past ten years .